Published DateClear

Start Date

End Date

Category

• Business1
• Pipeline1
• Research1

Organizations

• Bausch + Lomb77
• Eyes On Eyecare58
• Alcon, Inc.52
• American Optometric Association42
• Harrow35
• Glaukos31
• Topcon Healthcare26
• Regeneron25
• Coopervision23
• Aldeyra Therapeutics21

Tags

• Keratitis3
• Cornea2
• Acanthamoeba Keratitis1
• Corneal Cross Linking1
• Eye Drop Solution1
• Eye Drops1
• Finance1
• Finances1
• Financial1
• Licensing Agreement1

• Organizations: Provectus Biopharmaceuticals✕

Clear all

Pipeline

Provectus and VisiRose patent light-free eye drop for drug-resistant BK

Intellectual property covers topical RBS ophthalmic solution against resistant Gram-positive bacteria without the need for light activation.

Business

VisiRose raises $3M to advance RB-PDAT therapeutic toward regulatory approval

Funding will support ongoing clinical development of photodynamic therapy candidate for infectious keratitis and future IND submission to FDA.

Research

Provectus and MiamiU sign global licensing agreement for eye infection therapy

Deal involves developing and commercializing a proprietary photodynamic antimicrobial therapy with a formulation of rose bengal sodium.